S&P Futures
4,029.00 -3.50 (-0.09%) Dow Futures
33,756.00 -29.00 (-0.09%) Nasdaq Futures
11,935.75 -32.25 (-0.27%) Russell 2000 Futures
1,892.30 -1.20 (-0.06%) Crude Oil
77.48 -0.42 (-0.54%) Gold
1,929.20 -10.00 (-0.52%)
AMRN Jun 2023 3.000 put
| Previous Close | 1.7500 |
| Open | 1.7500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 3.00 |
| Expire Date | 2023-06-16 |
| Day's Range | 1.7500 - 1.7500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- Barrons.com
Amarin and ViewRay Stock See Action From Activist Investors
Sarissa Capital is pushing to get a slate of directors on the board of pharmaceutical firm Amarin. Hudson Executive disclosed a large stake in radiation-treatment equipment maker ViewRay.
- GlobeNewswire
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Medsafe in New Zealand has granted approval to VAZKEPA (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in adult statin-treated patients with high CV risk with elevated triglycerides. Cardiovascular disease is a significant health issue for people li
- GlobeNewswire
Amarin to Present at SVB Securities Global Biopharma Conference
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the SVB Securities Global Biopharma Conference. SVB Securities Global Biopharma Conference (February 13-16th, 2023; Virtual) Date/Time: February 14, 2023 10:40 a.m. ET Webcast: https://wsw.com/webcast/svb8/register.aspx?conf=svb8&page=amrn&url=https://wsw.com/webcast/svb8/am
